Cochlear (ASX:COH) reported Friday that its six-month earnings per diluted share rose to AU$3.125 from AU$2.913 per diluted share a year earlier.

Analysts polled by Visible Alpha were expecting EPS of AU$3.17.

Underlying earnings were AU$3.139 per basic share, compared with AU$2.925 a year earlier.

Total revenue for the half year ended Dec. 31, 2024, was AU$1.17 billion, compared with AU$1.1 billion a year earlier. Analysts surveyed by Visible Alpha expected total revenue of AU$1.2 billion.

Sales revenue was AU$1.17 billion, up from AU$1.11 billion in the same period a year earlier.

The medical device firm expects 2025 underlying net profit at the lower end of the AU$410 million to AU$430 million guidance provided in August 2024. It also expects cochlear implant unit growth of around 10%.

The board declared an interim dividend of AU$2.15 per share, up from the AU$2 in the previously reported period, payable on April 14 to shareholders on record as of March 21.